X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ENLV

Closed

Enlivex Therapeutics Ltd

1.12
0.00 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.12
Day's Range: 1.11 - 1.16
Send
When Written:
 
3.64
Enlivex Therapeutics Ltd is a clinical-stage biopharmaceutical company that develops immunotherapy treatments for various medical conditions such as sepsis, solid tumors, and autoimmune diseases. The company's proprietary Allocetra technology is designed to harness the power of the immune system to treat these diseases.

Enlivex's lead product candidate, Allocetra-OTS, is currently in Phase II clinical trials for the treatment of sepsis. The company is also developing Allocetra-SC for the treatment of solid tumors and autoimmune diseases.

Enlivex was founded in 2005 and is headquartered in Ness Ziona, Israel. The company went public on the Nasdaq stock exchange in 2018 under the ticker symbol "ENLV".

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X